NCT04145349 2025-12-08
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Eli Lilly and Company
Phase 1/2 Active not recruiting
Eli Lilly and Company
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Celgene
Puma Biotechnology, Inc.
Incyte Corporation